Interferon alpha 2 (IFNA2) (NM_000605) Human Recombinant Protein
CAT#: TP720005
Recombinant protein of human interferon, alpha 2 (IFNA2)
View other "Interferon alpha 2" proteins (6)
Need it in bulk or customized? Get a free quote |
CNY 3,140.00
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Species | Human |
Expression Host | E. coli |
Expression cDNA Clone or AA Sequence |
Cys24-Glu188
|
Tag | Tag Free |
Predicted MW | 19.4 kDa |
Concentration | lot specific |
Purity | >95% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | Lyophilized from a 0.2 um filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Storage | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
Stability | Stable for at least 6 months from date of receipt under proper storage and handling conditions. |
Bioactivity | Specific Activity is greater than 1.0 x 108 IU/ mg as determined by a viral resistance assay using VSV-WISH cells. |
Endotoxin | < 0.1 EU per µg protein as determined by LAL test |
Reference Data | |
RefSeq | NP_000596 |
Locus ID | 3440 |
UniProt ID | P01563 |
Cytogenetics | 9p21.3 |
Synonyms | IFN-alpha-2; IFN-alphaA; IFNA; IFNA2B; leIF A |
Summary | This gene is a member of the alpha interferon gene cluster on chromosome 9. The encoded cytokine is a member of the type I interferon family that is produced in response to viral infection as a key part of the innate immune response with potent antiviral, antiproliferative and immunomodulatory properties. This cytokine, like other type I interferons, binds a plasma membrane receptor made of IFNAR1 and IFNAR2 that is ubiquitously expressed, and thus is able to act on virtually all body cells. The encoded protein is effective in reducing the symptoms and duration of the common cold and in treating many types of cancer, including some hematological malignancies and solid tumors. A deficiency of type I interferon in the blood is thought to be a hallmark of severe COVID-19 and may provide a rationale for a combined therapeutic approach. [provided by RefSeq, Aug 2020] |
Protein Families | Druggable Genome, Secreted Protein |
Protein Pathways | Antigen processing and presentation, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Regulation of autophagy, RIG-I-like receptor signaling pathway, Toll-like receptor signaling pathway |
Documents
FAQs |
SDS |
Resources
蛋白相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
LC400201 | IFNA2 HEK293T cell transient overexpression lysate (as WB positive control) |
CNY 900.00 |
|
LY400201 | Transient overexpression lysate of interferon, alpha 2 (IFNA2) |
CNY 3,080.00 |
|
PH321091 | IFNA2 MS Standard C13 and N15-labeled recombinant protein (NP_000596) |
CNY 19,520.00 |
|
TP321091 | Recombinant protein of human interferon, alpha 2 (IFNA2), 20 µg |
CNY 2,900.00 |
|
TP720019 | Recombinant protein of human interferon, alpha 2 (IFNA2) |
CNY 3,140.00 |
|
TP723881 | Purified recombinant protein of Human interferon, alpha 2 (IFNA2) |
CNY 4,090.00 |
其它Interferon alpha 2产品